The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?
Abstract
OBJECTIVE: In this study, our aim was to determine total oxidative stress and asymmetric dimethylarginine (ADMA) levels in patients with masked hypertension (MHT) and to examine their association with blood pressure. METHODS: Fifty patients diagnosed with MHT and 48 healthy volunteers without any known chronic diseases have been included in this study. RESULTS: When compared to the control group, patients with MHT had higher levels of mean ADMA (p < 0.001), total oxidant status (TOS) (p < 0.001), and oxidative stress index (OSI) (p < 0.001), and a lower mean total antioxidant status (TAS) (p < 0.001) level. While a positive correlation was determined between the systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels with ADMA, TOS, and OSI levels, a negative correlation was determined with the TAS level. During the stepwise multivariable logistic regression analysis, age (OR = 1.221; p = 0.003), body mass index (OR = 1.512; p = 0.005), low density lipoprotein (OR = 0.925; p = 0.016), ADMA (OR = 1.200; p = 0.002), and OSI (OR = 3.750; p = 0.002) levels were determined to be the predictors of MHT. During the linear regression analysis, it was determined that the independent risk factors of SBP and DBP are ADMA and OSI, and the independent risk factor of TOS, OSI, and ADMA is SBP. Our study found out that oxidative stress and ADMA levels of patients with MHT are higher than those of the control group. ADMA and OSI were determined to be predictors of MHT. CONCLUSION: Based on these results, it could be said that oxidative stress, and therefore the ADMA level, could have an effect on the etiopathogenesis of MHT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have demonstrated that individuals with atherosclerosis, chronic heart failure [16, 17], hypertension [18], hypercholesterolemia [19], and diabetes mellitus [20], as well as women with PCOS [21], exhibit elevated levels of ADMA [22].”
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,764
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
Hadi, H. A. R., Carr, C. S., & Suwaidi, J. M. S. A. (2005) · PubMed Central · Cited by 830
Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553
European Society of Hypertension Practice Guidelines for home blood pressure monitoring
Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., Kario, K., Lurbe, E., Manolis, A., Mengden, T., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.54 · Cited by 482
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Sibal, L., Agarwal, S. C., Home, P., & Böger, R. H. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791162659 · Cited by 446
Sydow, K., & Münzel, T. F. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00033-3 · Cited by 434
Mechanisms of Disease: pre-eclampsia
Noris, M., Perico, N., & Remuzzi, G. (2005) · Nature Reviews Nephrology · doi:10.1038/ncpneph0035 · Cited by 324
LEIPER, J. M., Murray‐Rust, J., McDonald, N. Q., & Vallance, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212269799 · Cited by 288
Factors contributing to the outcome of oxidative damage to nucleic acids
Evans, M. D., & Cooke, M. S. (2004) · BioEssays · doi:10.1002/bies.20027 · Cited by 279
Research works printed but not linked: 6
- Ates I, 2015, Scand Cardiovasc J, 0, 1
- 10.1191/1358863x05vm598oa · DOI
- Colonna VDG, 2009, Med Sci Monit, 15, RA91
- Mancia G, 2013, Eur Heart J 2013, 34, 2159
- Hadi HA, 2005, Vasc Health Risk Manag, 1, 183
- Vaziri ND., 2008, Iran J Kidney Dis, 2, 1
Cited by
Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications
Große, G. M., Schwedhelm, E., Worthmann, H., & Choe, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051798 · Cited by 54
Fan, W., Qu, X., Li, J., Wang, X., Bai, Y., Cao, Q., Ma, L., Zhou, X., Zhu, W. P., Liu, W. Y., et al. (2017) · Scientific Reports · doi:10.1038/srep41683 · Cited by 32
Gkaliagkousi, Ε., Gavriilaki, E., Triantafyllou, Α., Nikolaidou, B., Anyfanti, P., Koletsos, N., Vamvakis, A., Δίπλα, Κ., Lazaridis, A. A., & Δούμα, Σ. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13237 · Cited by 29
Ochoa‐Martínez, Á. C., Cardona-Lozano, E. D., Carrizales, L., & Pérez‐Maldonado, I. N. (2017) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-017-0491-9 · Cited by 23
Zheng, P., Li, S., Liu, C., Zha, Z., Xiang, W., & Yuan, Y. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1411497 · Cited by 12
Total methylated arginine load as a risk parameter in subjects with masked hypertension
Hosaf, M., Abuşoğlu, S., Avcı, A., Demır, K., Ünlü, A., Eryavuz, D., & Abuşoğlu, G. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1583246 · Cited by 6
Atherosclerosis and Autoimmunity
Spinelli, F. R., Barone, F., Cacciapaglia, F., Pecani, A., & Piga, M. (2018) · Mediators of Inflammation · doi:10.1155/2018/6730421 · Cited by 6
Masked arterial hypertension: what is known and what expected to be learned?
Gorshkov, A. Y., Александрович, Ф. А., & Drapkina, O. M. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202023062143 · Cited by 4
Amirkhizi, F., Taghizadeh, M., Hamedi-Shahraki, S., & Asghari, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00932-1 · Cited by 3
“Studies have demonstrated that individuals with atherosclerosis, chronic heart failure [16, 17], hypertension [18], hypercholesterolemia [19], and diabetes mellitus [20], as well as women with PCOS [21], exhibit elevated levels of ADMA [22].”
Relationship between endothelial dysfunction and development of complications of metabolic syndrome
Мустафаева, А. Г. (2018) · Kazan medical journal · doi:10.17816/kmj2018-784 · Cited by 2
Atherosclerosis and Autoimmunity
Perricone, C., Spinelli, F. R., & Shoenfeld, Y. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00005-3 · Cited by 1
The role of asymmetric dimethylarginine in the development of arterial hypertension.
Podzolkov, V. I., Safronova, T. A., & Умарбековна, Н. Д. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-11-965-970 · Cited by 1
Chen, X., Xia, L., Xiang, T., & Wang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1174777/v1 · Cited by 1
Effect of Increasing the Plasma Phospholipase A2 Mass on the Risk of Masked Hypertension in Humans
Gao, Y., Ling, L., Yuan, C., & Ying, C. (2019) · Biochemistry and Modern Applications · doi:10.33805/2638-7735.125
Metadata
- Authors
- Inan, B., Ates, I., Ozkayar, N., Kundi, H., Topcuoglu, C., Dede, F., & Sennaroglu, E.
- Affiliations
- Ankara Numune Eğitim ve Araştırma Hastanesi (TR)
- Venue
- Clinical and Experimental Hypertension
- Publisher
- Informa UK Limited
- Published
- 2016-03-28
- Volume
- 38
- Issue
- 3
- Pages
- 294-298
- ISSN
- 0148-3927 (ISSN-L)
- 1064-1963
- 1525-6006
- OpenAlex
- W2322763843
- Cited by
- 14
- References
- 26
- Citations by year
- 2025: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 4
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical and Experimental Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- masked hypertension, oxidative stress, asymmetric dimethylarginine, total oxidant status, oxidative stress index, total antioxidant status, blood pressure, risk factors, endothelial dysfunction, LDL cholesterol, body mass index
- MeSH terms
- Adult, Age Factors, Antioxidants, Arginine, Blood Pressure, Blood Pressure Determination, Female, Humans, Lipoproteins, LDL, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Statistics as Topic, Body Mass Index, Oxidants, Oxidative Stress, Masked Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.